Sponsored By




Vote Erika Smith

for Entrepreneur

ReNetX Bio



Erika R. Smith






ReNetX Bio


City/Town where Organization Located

New Haven


City/Town of Residence - this is for media placement



Company/organization description (<500 characters)

ReNetx Bio – a clinical stage company established to provide first-in-class therapeutics to treat damage to the central nervous system (CNS). The company's scientific founder, Dr. Stephen Strittmatter from Yale University, identified key factors that inhibit regrowth in the CNS. The company's novel protein therapeutic approach binds these inhibitors thereby enabling nerve fiber regrowth and increased synaptic plasticity for neural reconnection. ReNetX Bio has raised $25M, launched a Phase 1/2 clinical trial proof of concept trial and was granted "Fast Track Designation" from FDA.


Tell us about the entrepreneurial milestones you accomplished in 2019 (<500 characters) e.g., patents received, growth rate, and successful MVP, trial, or exit, etc…

Fast Track Designation from FDA, Launched Phase 1/2 Clinical Trial for Spinal Cord Injury, Entrepreneur of the Year - BioCT, Selected by New Haven Biz Innovation Awards 60 Ideas in 60 Minutes, Launched Executive Women in Bio (Diversity initiative)


What type of entrepreneur are you? Scaling Company: regional, national, or global business focus and greater than $1,000,000 in revenue in 2019; Scalable Venture: regional, national, or global business focus and less than $1,000,000 in revenue in 2019; Main Street: local business focus;Social Good: social enterprise or nonprofit focus

Scalable Venture


Student entrepreneur: Are you a student and younger than 25 as of December 31, 2019? YES or NO



What CT entrepreneur ecosystem resources (spaces, programs, events, schools, etc.) have helped you succeed? (<500 characters)

Connecticut Innovations, Yale, BioCT, New Haven Biz


What people are saying about Erika Smith ...

 Erika Smith is the CEO of ReNetX Bio, a clinical stage, privately held company, located in New Haven, CT committed to developing breakthrough, first in class therapies to reverse damage in patients with neurological disease and injury. Over the last 25 years, she successfully advanced dozens of companies and technologies in life-sciences by leading the launch of three investment funds: the Blavatnik Fund for Innovation at Yale, the YEI (Yale) Innovation Fund, and the Center for Innovative Technology (CIT) BioLife Fund in partnership with Johnson  

Bill Kenney





Others in this category


Adam Lazar


Alexa Curtis




Ali Lazowski


Amber Jones


Anurag Shah


April Lukasik


Ari Santiago


Armin Rad


Athena Filakos


Becky Butler


Bobbi Jo Beers


Brandon Blain


Brittany Molkenthin


Carol Dannhauser


Casey Scott


Chang Hun Lee


Chevon Schand


Christien Ducker


Christina Sciongay


Clarissa Lee


Connor Milican


Dan Sunderland


Daniel Flynn


Danny Briere


Dawn Reshen-Doty


Deborah Freeman


Donald Boermeester


Dr Artemis Morris


Eric Rosow


Foster Charles


Frank Musto


Gina Nisco


Griffin Bryan


Herm Sorcher


Jackie Post


Jason Clemence


Jayme Coates


Jeannette Dardenne


Jeffrey Devereux


Jennifer Cuevas


Jessica Bittner


Jim Kennedy


Jim Tully


Joe Sartori


Joel Miller


John Kenny


Johnny Bello


Jonathan Soares


Judy Ricker


Jully Patel


Justin Marti


Katushka Millones


Kenneth Carney


Kevin Hart


Kevin Lane


Kristina Lough


Lance A. Scott


Leila Daneshmandi


Leslie Gomez


Liz Ceppos


Margot Broom


Maria Brown


Marina Marmolejo


Marissa Squires


Mark Lassoff


Mark Mathias


Matt Moroney


Matthew Miale


Mckenna Haz


Michael Sauvageau


Ming Thompson


Mirela Panaitisor


Naheed Quaisar


Neha Kochar


Ona Hauert


Per Hellsund


Robert Goldberg


Sara Deren


Sarah Lopes


Scott Stephenson


Shannon Malkin Daniels


Stephen Robinson PhD


Steven Showalter


Tate Norden


Ted Dinsmore


Tim Moore


Trish Loter


Vaishali Shah


Wilder Rumpf


Zachary Fitzner



Escort Girl